Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species
- 23 May 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 42 (6) , 981-992
Abstract
Baicalein is the major bioactive flavonoid in some herb medicines and dietary plants; however, the detailed metabolism pathway of its major metabolite oroxylin A-7-O-β-d-glucuronide in human was not clear. It was important to illustrate the major metabolic enzymes that participate in its elimination for the clinic use of baicalein.Keywords
This publication has 39 references indexed in Scilit:
- Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9Xenobiotica, 2012
- Identification of phenolic compounds from Scutellaria lateriflora by liquid chromatography with ultraviolet photodiode array and electrospray ionization tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2012
- Association of COMT genotypes with S-COMT promoter methylation in growth-discordant monozygotic twins and healthy adultsBMC Medical Genetics, 2011
- Identification of the UDP-Glucuronosyltransferase Isozyme Involved in Senecionine Glucuronidation in Human Liver MicrosomesDrug Metabolism and Disposition, 2010
- Intestinal UGTs as potential modifiers of pharmacokinetics and biological responses to drugs and xenobioticsExpert Opinion on Drug Metabolism & Toxicology, 2007
- Involvement of UDP-Glucuronosyltransferases in the Extensive Liver and Intestinal First-Pass Metabolism of Flavonoid BaicaleinPharmaceutical Research, 2006
- HPLC with electrochemical detection to examine the pharmacokinetics of baicalin and baicalein in rat plasma after oral administration of a Kampo medicineAnalytical Biochemistry, 2006
- Absorption and enterohepatic circulation of baicalin in ratsLife Sciences, 2005
- Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tractJournal of Pharmacy and Pharmacology, 2005
- Site‐specific cytosine methylation in S‐COMT promoter in 31 brain regions with implications for studies involving schizophreniaAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005